基曼尼希基衍生物:合成,抗疟疾活动对抗Plasmodium knowlesi,以及分子对接分析
Jufrizal Syahri1, Rahmiwati Hilma1, Amatul Hamizah Ali2
1Department of Chemistry, Universitas Muhammadiyah Riau Jalan Tuanku Tambusai Ujung Pekanbaru Indonesia jsyachri@umri.ac.id.
RSC advances
|December 13, 2023
概括
新的石墨烯衍生物显示出作为抗疟疾药物对抗抗性虫寄生虫的承诺. 这些化合物表现出强烈的活性和高选择性,向二叶酸还原酶-甲基酸合成酶 (PfDHFR-TS).
科学领域:
- 药用化学 医学化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 寄生虫的抗药性需要新的抗疟疾药物.
- 修改 chalcones 上的氨基组替代物可以增强抗疟疾活性并减少交叉耐药性.
研究的目的:
- 为了合成具有氨基基群的新型石墨烯衍生物.
- 评估它们对Plasmodium knowlesi和Plasmodium falciparum的抗疟疾活性.
- 为了研究它们与Plasmodium falciparum二二酸盐减少酶-二基酸合成酶 (PfDHFR-TS) 的分子相互作用.
主要方法:
- 通过曼尼赫式反应合成石墨烯衍生物.
- 在体外对P. knowlesi和P. falciparum进行抗疟疾活性测试.
- 对抗PfDHFR-TS的分子对接模拟.
主要成果:
- 卡尔曼尼赫型基衍生物2a,2e和2h在P. knowlesi和P. falciparum的体外显示出强大的抗疟活性.
- 化合物2a,2e和2h对两种寄生虫菌株都表现出高选择性指数 (SI>10).
- 分子对接揭示了化合物2a,2e和2h与PfDHFR-TS.的强有力的结合亲缘关系 (CDOCKER能量).
结论:
- 基曼尼赫型基衍生物2a,2e和2h具有显著的抗疟疾潜力.
- PfDHFR-TS被确定为这些新型化合物的可能分子标.
- 这项研究支持开发这些衍生品作为新的抗疟疾药物候选药物.
更多相关视频
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.4K
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.9K
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
569
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
569
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
